What is the place in therapy for nirmatrelvir/ritonavir?
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
|---|---|
| Enthalten in: |
BMJ evidence-based medicine - 28(2023), 5 vom: 16. Okt., Seite 287-290 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lee, Todd C [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
7R9A5P7H32 |
|---|
| Anmerkungen: |
Date Completed 25.09.2023 Date Revised 28.09.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1136/bmjebm-2022-112064 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM348981171 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM348981171 | ||
| 003 | DE-627 | ||
| 005 | 20231226041553.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/bmjebm-2022-112064 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1163.xml |
| 035 | |a (DE-627)NLM348981171 | ||
| 035 | |a (NLM)36384743 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lee, Todd C |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a What is the place in therapy for nirmatrelvir/ritonavir? |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.09.2023 | ||
| 500 | |a Date Revised 28.09.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a THERAPEUTICS | |
| 650 | 7 | |a nirmatrelvir |2 NLM | |
| 650 | 7 | |a 7R9A5P7H32 |2 NLM | |
| 650 | 7 | |a Ritonavir |2 NLM | |
| 650 | 7 | |a O3J8G9O825 |2 NLM | |
| 700 | 1 | |a Pogue, Jason M |e verfasserin |4 aut | |
| 700 | 1 | |a McCreary, Erin K |e verfasserin |4 aut | |
| 700 | 1 | |a Morris, Andrew M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BMJ evidence-based medicine |d 2018 |g 28(2023), 5 vom: 16. Okt., Seite 287-290 |w (DE-627)NLM279942753 |x 2515-4478 |7 nnns |
| 773 | 1 | 8 | |g volume:28 |g year:2023 |g number:5 |g day:16 |g month:10 |g pages:287-290 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/bmjebm-2022-112064 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 28 |j 2023 |e 5 |b 16 |c 10 |h 287-290 | ||